“优秀的药企需要满足具有国际创新能力和全球竞争力等特征，当行业出现严重同质化之后，企业一定要去做具有‘全球新’的产品，并具有极强的执行力。当出现机会的时候，就能把握住机会，高质量、快速地把创新转化为成果。”科望医药联合创始人兼CEO纪晓辉博士说。在日前举行的“国际免疫创新研讨会”上，科望医药分享了公司自研“巨噬细胞衔接器平台BiME®”等前沿成果的最新进展。这家在浦东成立8年的“创新药”企业，专注...
Source Link“优秀的药企需要满足具有国际创新能力和全球竞争力等特征，当行业出现严重同质化之后，企业一定要去做具有‘全球新’的产品，并具有极强的执行力。当出现机会的时候，就能把握住机会，高质量、快速地把创新转化为成果。”科望医药联合创始人兼CEO纪晓辉博士说。在日前举行的“国际免疫创新研讨会”上，科望医药分享了公司自研“巨噬细胞衔接器平台BiME®”等前沿成果的最新进展。这家在浦东成立8年的“创新药”企业，专注...
Source LinkDisclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.